FLEMMING ORNSKOV, M.D., M.P.H.

Corporate Board Profile

Tech Score: 0/100

WATERS CORP /DE/

Filing Date	Source Excerpt
2019-04-04	Dr. Ornskov, 61, has served as a Director of the Company since June 2017. Dr. Ornskov brings operational and medical knowledge along with extensive international, strategic and operational experience in the pharmaceutical sector. Waters Committee Memberships: Compensation Committee, Nominating and Corporate Governance Committee, Science and Technology Committee. Director Compensation Fiscal Year 2018: Flemming Ornskov, M.D., M.P.H. Fees Earned or Paid in Cash $74,500, Stock Awards $109,978, Option Awards $109,995, Total $294,473.
2020-04-02	Flemming Ornskov, M.D., M.P.H. Chief Executive Officer of Galderma Director since 2017 Age: 62 Committees Compensation Nominating and Corporate Governance Science and Technology ...Dr. Ornskov brings both operational and medical knowledge along with an extensive international, strategic, and operational experience in the pharmaceutical sector both at senior leadership and board levels. ...Director Compensation Fiscal Year 2019 Flemming Ornskov, M.D., M.P.H. Fees Earned or Paid in Cash ($): $99,000 Stock Awards ($): $109,863 Option Awards ($): $110,000 Total ($): $318,863.

Filing Date

Source Excerpt

2019-04-04

Dr. Ornskov, 61, has served as a Director of the Company since June 2017. Dr. Ornskov brings operational and medical knowledge along with extensive international, strategic and operational experience in the pharmaceutical sector. Waters Committee Memberships: Compensation Committee, Nominating and Corporate Governance Committee, Science and Technology Committee. Director Compensation Fiscal Year 2018: Flemming Ornskov, M.D., M.P.H. Fees Earned or Paid in Cash $74,500, Stock Awards $109,978, Option Awards $109,995, Total $294,473.

2020-04-02

Flemming Ornskov, M.D., M.P.H. Chief Executive Officer of Galderma Director since 2017 Age: 62 Committees Compensation Nominating and Corporate Governance Science and Technology ...Dr. Ornskov brings both operational and medical knowledge along with an extensive international, strategic, and operational experience in the pharmaceutical sector both at senior leadership and board levels. ...Director Compensation Fiscal Year 2019 Flemming Ornskov, M.D., M.P.H. Fees Earned or Paid in Cash ($): $99,000 Stock Awards ($): $109,863 Option Awards ($): $110,000 Total ($): $318,863.

Data sourced from SEC filings. Last updated: 2026-02-03